What is NDC 71335-3131?

71335-3131 is the product NDC for Terazosin, Terazosin hydrochloride 5 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 4 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Terazosin?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Terazosin NDC 71335-3131 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3131Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3131Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3131-1	7133531310171335313101	100 CAPSULE in 1 BOTTLE (71335-3131-1)Marketed from May 21, 2026
71335-3131-2	7133531310271335313102	30 CAPSULE in 1 BOTTLE (71335-3131-2)Marketed from May 21, 2026
71335-3131-3	7133531310371335313103	90 CAPSULE in 1 BOTTLE (71335-3131-3)Marketed from May 21, 2026
71335-3131-4	7133531310471335313104	60 CAPSULE in 1 BOTTLE (71335-3131-4)Marketed from May 21, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Terazosin
Generic name (nonproprietary): terazosin
Active ingredients: Terazosin hydrochloride — 5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075667
Marketing start: Mar 11, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 71335-3131_12aa9f2d-da1f-43cf-a446-65c90c0503dfSPL ID 12aa9f2d-da1f-43cf-a446-65c90c0503dfSPL set ID b77a4a38-edb1-412e-97af-d49e862b32c1RxCUI 313219UNII D32S14F082
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335313101 followed by a unit qualifier and the quantity

Package 71335-3131-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules. The long-term effects of terazosin on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules are also indicated for the treatment of hypertension. It can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3131

What is NDC 71335-3131?: 71335-3131 is the product NDC for Terazosin, Terazosin hydrochloride 5 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Terazosin.
What is the active ingredient?: Terazosin hydrochloride.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Terazosin?: 61 other product NDCs are listed under this name. See all Terazosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Terazosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4064	68788-4064-0168788-4064-03
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4545	70518-4545-00
Terazosinterazosin hydrochloride	Terazosin hydrochloride 5 mg/1	CapsuleOral	Coupler LLC	67046-1622	67046-1622-03
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-288	27241-0288-0127241-0288-10
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-289	27241-0289-0127241-0289-10
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-290	27241-0290-0127241-0290-10
Terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Ajanta Pharma USA Inc.	27241-291	27241-0291-0127241-0291-10
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Bionpharma Inc.	69452-330	69452-0330-2069452-0330-32
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Bionpharma Inc.	69452-331	69452-0331-2069452-0331-32
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Bionpharma Inc.	69452-332	69452-0332-2069452-0332-32

All 62 Terazosin NDCs

Other NDCs under ANDA 075667

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075667
Product	Strength	Form · route	Labeler	Product NDC
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4064
Terazosin	Terazosin hydrochloride 1 mg/1	CapsuleOral	Bionpharma Inc.	69452-330
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Bionpharma Inc.	69452-331
Terazosin	Terazosin hydrochloride 5 mg/1	CapsuleOral	Bionpharma Inc.	69452-332
Terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Bionpharma Inc.	69452-333
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4545
Terazosin	Terazosin hydrochloride 2 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-3059
Terazosin	Terazosin hydrochloride 10 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-3123